Biopool sells blood bank reagent business to Immucor
This article was originally published in Clinica
Executive Summary
Biopool International is to sell its immunohaematology (blood bank reagent) business to Immucor, for a total of $4.5 million. The Ventura, California-based company plans to use the cash brought in by the deal to acquire companies in its core haemostasis and cardiovascular disease segments.